<scp>DRD1</scp> suppresses cell proliferation and reduces <scp>EGFR</scp> activation and <i>PD‐L1</i> expression in <scp>NSCLC</scp>
Christopher E. Grant(National Cancer Institute), Bríd M. Ryan(National Institutes of Health)
Cited by 9
Related Papers
Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium
|Journal of Thoracic Oncology|2022|26
Accounting for <i>EGFR</i> Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data
|Cancer Epidemiology Biomarkers & Prevention|2022|2